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Two peptide sequences from Park9 Parkinson’s disease gene, P1D2E3K4H5E6L7 (1) and F1C2G3D4G5A6N7D8C9G10 
(2) have been studied in their interaction with Mn(II) and Zn(II) ions. These fragments lie from residue 1165 to 1171 
and from 1184 to 1193 in the Park9 encoded protein, that can protect cells from manganese poisoning, an 
environmental risk factor for a Parkinson’s disease-like syndrome called Manganism. The study was carried out 
through potentiometric and spectroscopic (UV-Vis, EPR, mono- and multidimensional NMR) techniques, to cast 
light on the details of metal binding at different pH values and different ligand to metal molar ratios. 
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Introduction 
Recently, a connection between genetic and environmental causes of Parkinson’s disease (PD) has been reported 
[1,2]. It was known that environmental and occupational exposure to Mn(II) [3] can lead to symptoms that resemble 
Parkinson’s disease, called Parkinsonism or Manganism [4], but two articles appearing almost at the same time in 
the literature showed that a human PD gene, PARK9 (a member of the P5-type ATPase family, perhaps a metal 
transporter, considering its richness in coordinating residues), and its homologue in yeast, YPK9, can prevent 
manganese- induced PD and protect neurons and cells from manganese poisoning [1]. In fact, deletion of the 
YPK9 gene, which is 58% similar and 38% identical in its amino acid sequence to human PARK9, confers 
sensitivity to growth defects in the presence of cadmium, nickel, selenium, and manganese, suggesting that YPK9 
protein may play a role in the sequestration of divalent heavy metal ions. In the same way, a mutation on PARK9 
may expose humans to these cations, especially to manganese. We have thus decided to verify the possibility of 
metal binding to some simplified portions of PARK9 and YPK9, by choosing promising sites for metal interaction 
due to the presence of coordinating residues, far from the membrane-spanning and the alpha-helical rich domains 
not easily accessible by metals, and taking into account highly conserved binding motifs on both PARK9 and 
YPK9. We identified two interesting fragments and tested them for metal binding with manganese and zinc [5,6]. 
Materials and methods 
Peptides were synthesized using solid-phase Fmoc chemistry in an Applied Biosystems Synthesizer. Peptides 
were N-terminally acetylated and C-terminally amidated in order to mimic this region of YPK9 within the full-length 
protein. 
NMR experiments were performed on a Bruker AscendTM 400 MHz spectrometer equipped with a 5 mm automated 
tuning and matching broad band probe (BBFO) with z-gradients. Samples were 2.5 or 5 mM in concentration and 
dissolved in 90/10 (v/v) H2O/D2O solutions, at 298 K in 5 mm NMR tubes. NMR data were processed with TopSpin 
(Bruker Instruments) software and analyzed by Sparky 3.11 MestRe Nova 6.0.2 (Mestrelab Research S.L.) 
programs. 
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Potentiometric titrations were performed with Orion EA 940 and Orion 720A pH-meters equipped with a combined 
glass electrode (Metrohm EA125), Hamilton MicroLab M and MicroLab300 motor burettes, and Hamilton syringes. 
The temperature was kept at 298.2 ± 0.1 K by use of a thermostat. All measurements were carried out under 
nitrogen atmosphere. 
EPR spectra were recorded with an X-band (9.4 GHz) Bruker EMX spectrometer, 100 kHz field modulation, at 120 
K on neat aqueous solutions or mixed with few drops of ethylene glycol, at different ligand to metal molar ratios, 
ranging from 1:0.2 to 1:1, pH 7 and 1 mM peptide concentration. 
Results and discussion 
Peptide 1, P1D2E3K4H5E6L7 
Only mono-nuclear complexes have been potentiometrically detected in the systems containing Mn(II) and the 
investigated peptides, and the speciation diagrams are in agreement with the results found with NMR, UV-vis and 
EPR measurements. 
Mn(II) is a paramagnetic ion, thus the effect of its addition to peptide 1 and 2 was monitored through the NMR line 
broadening and/or disappearance it causes on the resonances of the free ligand (Fig.1). 
 
Fig. 1 Selection of aliphatic regions in 1H-13C HSQC NMR spectra for the Ac-P1D2E3K4H5E6L7- Am peptide, 2.5 mM, 
pH 6.2, T 298 K in the absence (orange) and in the presence (blue) of 0.1 equivalents of Mn(II). 
As expected whenever a histidine residue is present on a peptide fragment coordinating a metal, this was the 
favoured binding site for both Mn(II) and Zn(II) ions with peptide 1. 
From the different sets of experiments performed, it was clear that once His5 has anchored the peptide at slightly 
acidic pH, other residues are involved in coordination as the pH is raised. Mn(II) progressively affected the 
relaxation rates of the amidic HN protons from the backbone together with the complete disappearance of Asp2, 
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Glu3 and Glu6 aliphatic protons signals in the 2D TOCSY spectra, and a decrease or total loss of their proton–
carbon correlations in the 2D 1H-13C HSQCs. 
Moreover, the analysis of the aliphatic HSQC region revealed that Qγ protons of Glu3 and Glu6 vanished upon 
Mn(II) addition, indicating that glutamic carboxylic groups are involved in the coordination, a fate shared also by the 
aspartate residue. All the other signals remained unaffected upon manganese addition. From the analysis of the 
data thus collected, the donor groups involved in metal coordination might be the Nε nitrogen from the imidazole 
ring of His5, and the γ-O from three carboxylic moieties of Asp2, Glu3 and Asp6 side-chains (Fig 1). 
EPR spectra of the Mn(II) complexes reflect the symmetry of the electronic environment of the ion which is imposed 
by the ligands in the primary coordination sphere. Changes in the composition or geometric arrangement of the 
ligands in the coordination sphere of the metal ion lead to changes in the position of the EPR spectral lines. The 
Mn(II)–peptide 1 spectra are almost indistinguishable from those of free Mn(II). The spectral identity indicated that 
the interaction, in aqueous solution, between the ligand and Mn(II) ions does not affect the electronic structure of 
the metal ion itself. Thus, it is possible that the peptide does coordinate to Mn(II) by displacement of aqua ligands; 
however, the six donor set and coordination geometry is almost maintained so that the zfs parameters remain 
nearly unchanged. The spectra are in agreement with an octahedral or distorted octahedral geometry, probably 
involving bidentate interaction of carboxyl groups carboxyl groups (Fig. 2b). 
 
Fig. 2 a) The model of the YPK9 protein built with ESyPred3D using the 3D crystal structure of the sodium-
potassium pump (PDB 3B8E chain A) as the template, and the 3D structural models proposed for b) the Mn(II) ion 
complexed with Ac-P1D2E3K4H5E6L7-Am and c) with the Ac- F1C2G3D4G5A6N7D8C9G10-Am peptide. 
Diamagnetic zinc ion was studied in order to have more information about the coordination behaviour of both 
investigated peptides. In fact, we were able to observe that the signals affected by diamagnetic shift under zinc 
interaction were the same which experienced paramagnetic broadening under manganese interaction, suggesting 
that the donor atoms involved in the coordination with peptide 1 are the same for both metal ions. In addition, a 
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change in the resonances for HN and Hγ2 of Lys4, and for HN of Leu7 shows that these two residues, although not 
directly involved in the complex formation, experience a new electronic environment after metal coordination. 
Peptide 2, F1C2G3D4G5A6N7D8C9G10 
Coordination of manganese to peptide 2 starts with the binding to a cysteine residue, as evidenced by the 
broadening of its signals already at very low metal concentration. So, in the absence of a histidine residue, cysteine 
acts as the anchoring site for the metal ion. In fact, Mn(II) progressively affected the relaxation rates in the 
resonances of both Cys2 and Cys9 with a complete disappearance of their signals in the 2D TOCSY spectra and 
the total loss of their proton–carbon correlations in the 2D 1H-13C HSQCs (Fig. 3). 
 
Fig. 3 Aliphatic regions of 1H-13C HSQC NMR spectra of the Ac-F1C2G3D4G5A6N7D8C9G10-Am peptide, 2.5 mM, pH 
6.3, T 298 K, in the absence (orange) and in the presence (blue) of 0.1 equivalents of Mn(II). 
Asp4 and Asp8 residues experience the main difference in the observed Mn(II)-induced effects for the carbon and 
proton frequencies, indicating that they take part, together with the cysteine residues, in the complex formation, 
most likely through their carboxyl groups (Fig. 2c). The presence of the paramagnetic metal provides a signal 
relaxation also for HN protons of Gly5, Ala6 and Asn7 residues. This behaviour could be due to an indirect 
paramagnetic line broadening effect caused by a through-space relaxation of these residues along the peptide 
chain which happen to be close to the Mn(II) centre. 
The EPR spectra of Mn(II)–peptide 2 complex and of free Mn(II) ion in aqueous (glass) solution show that they are 
qualitatively the same in the resolved sextet region, but the overall breadth of the pattern is a little different, 
indicating that the axial zfs parameter is different for the Mn–peptide species. This can be explained by a decrease 
in the number of water ligands around Mn(II) in the presence of the peptide fragment, suggesting their replacement 
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by oxygen and sulphur donor atoms. Diamagnetic NMR with Zn(II) ions evidenced that the residues involved in 
metal coordination are those experiencing the strongest chemical shift differences: Cys2 and Cys9. Other residues 
appear to be indirectly interested in the complex formation by slight perturbations: Phe1, Gly3, Asp8 and Gly10. 
Gathering the results from the NMR experiments we are able to infer that zinc coordination to peptide 2 involved 
the sulphur donors from the two cysteine side chains, forming a macrochelate complex. It is interesting to point out 
that the involvement of the two carboxylic groups from Asp4 and Asp8, in contrast to manganese coordination, has 
not been evidenced for Zn(II) coordination, thus indicating that, in this case, the behaviour of peptide 2 is different 
as a function of the different metal ion. 
Conclusions 
The preliminary results of the study on these two Park9 protein fragments show that both metals are able to bind 
them in an effective way, although with different coordination features depending on the fragment chosen, 
evidencing that portions of the same protein can interact in different ways with different ions. Although the 
fragments used are small and only represent a part of the entire protein, nevertheless this kind of study may 
provide insight in the divalent cations trafficking (transportation, detoxification) within the cell, at the base of the 
connection between genetic and environmental Parkinson’s disease causes. Further investigations, involving 
bigger domains of PARK9/YPK9 protein, are planned to shed light on the role of the entire protein in sequestering 
manganese and in the involved detoxification mechanism. 
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